Prenatal diagnosis is done for the women to prevent the genetic disorders in their babies. During the routine pregnancy period, if the results of blood tests and ultrasound are abnormal then a doctor may ask for the amniocentesis and chorionic villus sampling procedures. The prenatal diagnosis allows to detect the genetic defects and other disorders in the baby and helps parents to take decision of continuing the pregnancy.
MARKET DYNAMICS
The prenatal diagnostics market is estimated to grow due to the driving factors such as rising genetic disorders such as Down syndrome, sickle cell disease and others. The market is expected to grow due to the rising genetic based research, increasing genetic diagnosis, growing birth rate and others. The market is expected to have several growth opportunities in the emerging and developing regions where the population is growing exponentially.
MARKET SCOPE
The "Global Prenatal Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of prenatal diagnostics market with detailed market segmentation by procedure, product & services, application and end user and geography. The global prenatal diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading prenatal diagnostics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global prenatal diagnostics market is segmented on the basis of procedure, product & services, application and end user. Based on the procedure the market is segmented as ultrasonography, chorionic villus sampling, amniocentesis, percutaneous umbilical blood sampling, and preimplantation genetic diagnosis. On the basis of product & services the market is classified as instruments, consumables, and services. Based on the application the market is segmented as chromosome abnormality, and genetic disorders. On the basis of end user the market is categorized as hospitals, diagnostic laboratories.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global prenatal diagnostics market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The prenatal diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting prenatal diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the prenatal diagnostics market in these regions.
MARKET PLAYERS
The reports cover key developments in the prenatal diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from prenatal diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for prenatal diagnostics market in the global market. Below mentioned is the list of few companies engaged in the prenatal diagnostics market.
The report also includes the profiles of key prenatal diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- GE Healthcare (General Electric Company)
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- F. Hoffman-La Roche Ltd.
- Beijing Genomics Institute
- Agilent Technologies, Inc.
- Perkinelmer, Inc.
- Hologic, Inc.
- Natera, Inc.
- Quest Diagnostics, Inc.